Dr. Beant Singh Gill, MD

Dr. Gill practices at Associates in Radiation Medicine in Waldorf, Maryland.

Dr. Gill's NPI, 1770874513, was assigned on April 27, 2011. Dr. Gill graduated from George Washington University School of Medicine in 2011. Dr. Gill holds Pennsylvania license MD457962.

Dr. Gill's primary practice is Associates in Radiation Medicine, at 11340 Pembrooke Sq, Waldorf, MD 20603 in Charles County. The practice phone is (301) 805-6860.

Dr. Gill's primary practice is Associates in Radiation Medicine in Waldorf, Maryland. Dr. Gill is also affiliated with TidalHealth Peninsula Regional. The medical group on file is Associates in Radiation Medicine. Dmand AI also links Dr. Gill to 2 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gill practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Gill's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Gill is licensed in Pennsylvania.

Dmand AI lists bladder cancer radiation, bone cancer radiation, brain cancer radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation, head & neck cancer radiation and lung cancer radiation among the conditions Dr. Gill treats.

CMS data shows 4,382 Medicare services from Dr. Gill across 21 procedure codes in 2024, for 493 Medicare patients. Medicare paid $719,509 for them. Every service was in an office.

CMS counts 493 Medicare patients who saw Dr. Gill in 2024. The largest group is 65 to 74, with 234 patients. 75% of them have cancer, and 75% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gill's median patient age at 71, with 35% women.

In 2024, Dr. Gill wrote 158 Medicare Part D claims for 69 patients. 97% of them were for generic drugs. CMS names the drug for 80 of them, across 5 drugs with 11 or more claims each, at $4,378 in total drug cost. In 2023, CMS named 43 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Dr. Gill for performance year 2024, reported individually. Dr. Gill accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gill as offering telehealth.

Dmand AI links 44 papers to Dr. Gill, published from 2011 to 2018. 2015 was the busiest year, with 12. The most frequent topics are Radiotherapy Dosage, Brachytherapy and Endometrial Neoplasms. Dr. Gill has published most often in Front Oncol. Dr. Gill's most frequent co-authors are Sushil Beriwal, MD, Paniti Sukumvanich and Mark Edmund Bernard, MD.

CMS Open Payments shows 25 general payments to Dr. Gill from 15 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Elekta, Inc. paid the most, $376.

Dr. Gill graduated from George Washington University School of Medicine in 2011.

Dr. Gill is in network with 17 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.